SLC6A4, solute carrier family 6 member 4, 6532

N. diseases: 440; N. variants: 28
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.700 GeneticVariation disease BEFREE In humans, the short allele of a common polymorphism in the serotonin transporter (5-HTT) gene is associated with a higher risk to develop depression and anxiety disorders. 31849623 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.600 Biomarker group BEFREE 5-HTT knockout mice, lacking the 5-HTT gene either homo- or heterozygously, provide a widely used model organism for the study of symptoms related to human anxiety disorders. 31849623 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.600 GeneticVariation disease BEFREE In humans, the short allele of a common polymorphism in the serotonin transporter (5-HTT) gene is associated with a higher risk to develop depression and anxiety disorders. 31849623 2019
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.400 GeneticVariation phenotype BEFREE In humans, the short allele of a common polymorphism in the serotonin transporter (5-HTT) gene is associated with a higher risk to develop depression and anxiety disorders. 31849623 2019
CUI: C2937365
Disease: Recurrent aphthous ulcer
Recurrent aphthous ulcer
0.030 Biomarker disease BEFREE Our study indicates a possible relationship between SLC6A4 and susceptibility to RAS in the Czech population. 31846848 2020
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.100 PosttranslationalModification disease BEFREE Increased rsFC in the salience network mediated the link between SLC6A4 methylation and eating disorder symptoms in patients with anorexia nervosa. 31823595 2019
CUI: C0004936
Disease: Mental disorders
Mental disorders
0.100 GeneticVariation group BEFREE Epigenetic variation in the serotonin transporter gene (SLC6A4) has been shown to modulate the functioning of brain circuitry associated with the salience network and may heighten the risk for mental illness. 31823595 2019
CUI: C0013473
Disease: Eating Disorders
Eating Disorders
0.100 PosttranslationalModification group BEFREE Increased rsFC in the salience network mediated the link between SLC6A4 methylation and eating disorder symptoms in patients with anorexia nervosa. 31823595 2019
CUI: C0740858
Disease: Substance abuse problem
Substance abuse problem
0.340 GeneticVariation disease BEFREE While, there was no genetic association between the 5-HTTLPR (LL, LS, SS), rs25331 (AA, AG, GG) and tri-allelic (SASA, LASG, LASA, LALG, LALA) genotypes (P = 0.26, 0.71 and 0.52, respectively) and SUD. 31809838 2020
CUI: C0003125
Disease: Anorexia Nervosa
Anorexia Nervosa
0.100 PosttranslationalModification disease BEFREE Increased rsFC in the salience network mediated the link between SLC6A4 methylation and eating disorder symptoms in patients with anorexia nervosa. 31804778 2019
CUI: C0004936
Disease: Mental disorders
Mental disorders
0.100 GeneticVariation group BEFREE Epigenetic variation in the serotonin transporter gene (SLC6A4) has been shown to modulate the functioning of brain circuitry associated with the salience network and may heighten the risk for mental illness. 31804778 2019
CUI: C0013473
Disease: Eating Disorders
Eating Disorders
0.100 PosttranslationalModification group BEFREE Increased rsFC in the salience network mediated the link between SLC6A4 methylation and eating disorder symptoms in patients with anorexia nervosa. 31804778 2019
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.600 GeneticVariation disease BEFREE Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. 31792367 2019
CUI: C0549622
Disease: Sexual Dysfunction
Sexual Dysfunction
0.030 GeneticVariation group BEFREE It was also demonstrated that patients receiving SERT, carrying T allele of HTR2A or L allele of 5-HTTLPR more likely to experience SD. 31792367 2019
CUI: C0011581
Disease: Depressive disorder
Depressive disorder
0.700 GeneticVariation disease BEFREE Increasing evidence have indicated the strong association of stress, especially the chronic stress and early life stress, with depressive disorders development, while the association of stress with depression is moderated by genetic risk factors, including polymorphism of SERT, BDNF, GR, FKBP5, MR, and CRHR1. 31784962 2019
CUI: C0011570
Disease: Mental Depression
Mental Depression
0.600 GeneticVariation disease BEFREE Increasing evidence have indicated the strong association of stress, especially the chronic stress and early life stress, with depressive disorders development, while the association of stress with depression is moderated by genetic risk factors, including polymorphism of SERT, BDNF, GR, FKBP5, MR, and CRHR1. 31784962 2019
CUI: C0344315
Disease: Depressed mood
Depressed mood
0.400 GeneticVariation phenotype BEFREE Increasing evidence have indicated the strong association of stress, especially the chronic stress and early life stress, with depressive disorders development, while the association of stress with depression is moderated by genetic risk factors, including polymorphism of SERT, BDNF, GR, FKBP5, MR, and CRHR1. 31784962 2019
CUI: C0033975
Disease: Psychotic Disorders
Psychotic Disorders
0.100 Biomarker group BEFREE Compound S6, characterized by partial D<sub>2</sub> R agonism, 5-HT<sub>1A</sub> R agonism, 5-HT<sub>2A</sub> R antagonism, and blockade of SERT activities, was found to decrease psychosis- and depressive-like symptoms in rodents. 31746558 2019
CUI: C0349204
Disease: Nonorganic psychosis
Nonorganic psychosis
0.100 Biomarker disease BEFREE Compound S6, characterized by partial D<sub>2</sub> R agonism, 5-HT<sub>1A</sub> R agonism, 5-HT<sub>2A</sub> R antagonism, and blockade of SERT activities, was found to decrease psychosis- and depressive-like symptoms in rodents. 31746558 2019
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.600 Biomarker group BEFREE However, G x E interactions of 5-HTTLPR with high emotional impact and prior lifetime anxiety disorders were statistically significant. 31727442 2019
CUI: C0038436
Disease: Post-Traumatic Stress Disorder
Post-Traumatic Stress Disorder
0.100 GeneticVariation disease BEFREE These results provide new evidence of the modulation effect of the 5-HTTLPR polymorphisms on PTSD risk. 31727442 2019
CUI: C0041696
Disease: Unipolar Depression
Unipolar Depression
0.600 GeneticVariation disease BEFREE We investigated whether single nucleotide polymorphisms (SNPs) associated with neuroplasticity and activity of monoamine neurotransmitters, such as the brain-derived neurotrophic factor (BDNF, rs6265), the serotonin transporter (SLC6A4, rs25531), the tryptophan hydroxylase 1 (TPH1, rs1800532), the 5-hydroxytryptamine receptor 2A (HTR2A, rs6311, rs6313, rs7997012), and the catechol-O-methyltransferase (COMT, rs4680) genes, are associated with efficacy of transcranial direct current stimulation (tDCS) in major depression. 31721892 2019
CUI: C1269683
Disease: Major Depressive Disorder
Major Depressive Disorder
0.600 GeneticVariation disease BEFREE We investigated whether single nucleotide polymorphisms (SNPs) associated with neuroplasticity and activity of monoamine neurotransmitters, such as the brain-derived neurotrophic factor (BDNF, rs6265), the serotonin transporter (SLC6A4, rs25531), the tryptophan hydroxylase 1 (TPH1, rs1800532), the 5-hydroxytryptamine receptor 2A (HTR2A, rs6311, rs6313, rs7997012), and the catechol-O-methyltransferase (COMT, rs4680) genes, are associated with efficacy of transcranial direct current stimulation (tDCS) in major depression. 31721892 2019
CUI: C0438696
Disease: Suicidal
Suicidal
0.100 GeneticVariation disease BEFREE We hypothesized that, consistent with the gene X environment (GXE) framework, an interaction between serotonin receptor (5-HTTLPR) gene and drug use would influence suicidal behaviors in BD patients. 31707246 2020
CUI: C0242510
Disease: Drug usage
Drug usage
0.040 GeneticVariation phenotype BEFREE We hypothesized that, consistent with the gene X environment (GXE) framework, an interaction between serotonin receptor (5-HTTLPR) gene and drug use would influence suicidal behaviors in BD patients. 31707246 2020